US EditionNeurocrine Reports Quality of Life Gains for Older Adults Using INGREZZA
Summary by Arizona Daily Sun
12 Articles
12 Articles
All
Left
1
Center
7
Right
The Chandler Arizonan+10 Reposted by 10 other sources
Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia
Data Add to Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients Treated with INGREZZA for Tardive Dyskinesia Findings Presented at the 2025 American Association of Nurse Practitioners (AANP) National Conference
·Chandler, United States
Read Full ArticleCoverage Details
Total News Sources12
Leaning Left1Leaning Right0Center7Last UpdatedBias Distribution88% Center
Bias Distribution
- 88% of the sources are Center
88% Center
13%
C 88%
Factuality
To view factuality data please Upgrade to Premium
